EI-04

N/A

Report date: 2026/05/13 20:02:10
NME

Base Information

Drug NameEI-04
Drug Alias NameEI-04
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpidermal growth factor receptor erbB1 inhibitorsInsulin-like growth factor I receptor inhibitors
TargetsEpidermal growth factor receptor erbB1Insulin-like growth factor I receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiogen Idec
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiogen Idec
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A